Literature DB >> 971299

Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activity.

G L Dale, D G Villacorte, E Beutler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 971299     DOI： 10.1016/0006-291x(76)90760-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  19 in total

1.  Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation.

Authors:  E Beutler; G L Dale; D E Guinto; W Kuhl
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 2.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

Review 3.  Binding interactions of glycoproteins with lectins.

Authors:  J T Dulaney
Journal:  Mol Cell Biochem       Date:  1978-10-13       Impact factor: 3.396

4.  Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase.

Authors:  S Weiler; Y Kishimoto; J S O'Brien; J A Barranger; J M Tomich
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

5.  Newer aspects of some interesting lipid storage diseases: Tay-Sachs and Gaucher's diseases.

Authors:  E Beutler
Journal:  West J Med       Date:  1977-01

6.  Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity.

Authors:  E M Prence
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

7.  Evaluation of Disease Lesions in the Developing Canine MPS IIIA Brain.

Authors:  Leanne K Winner; Neil R Marshall; Robert D Jolly; Paul J Trim; Stephen K Duplock; Marten F Snel; Kim M Hemsley
Journal:  JIMD Rep       Date:  2018-06-20

8.  X-ray and biochemical analysis of N370S mutant human acid β-glucosidase.

Authors:  Ronnie R Wei; Heather Hughes; Susan Boucher; Julie J Bird; Nicholas Guziewicz; Scott M Van Patten; Huawei Qiu; Clark Qun Pan; Tim Edmunds
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

Review 9.  Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease.

Authors:  R O Brady; G J Murray; N W Barton
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.

Authors:  G L Dale; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.